Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Bosentan may represent new strategy for preventing cardiac and renal complications of hypertension

May 31, 1999

Enol metabolite of tasosartan appears not to contribute to pharmacodynamic effects

May 31, 1999

New, highly selective I1 receptor ligand with blood pressure-lowering effects

May 31, 1999

AGI-1067, a new vascular protectant, advances through the development pipeline

May 31, 1999

Long-term AT1 receptor blockade with fonsartan proves highly beneficial in SHR-SP

May 28, 1999

PD-098059 inhibits AII-induced MAPK activation in myocardial cells

May 28, 1999

Electrophysiological assessment of the sodium channel-blocking activity of RSD-921

May 26, 1999

Dietary omega-3 fatty acids have mild effect on coronary atherosclerosis

May 26, 1999

Transplantation news: neutrophil NADPH oxidase inhibitor improves functioning of preserved hearts

May 25, 1999

BASF describes new, selective ECE inhibitors

May 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...